Amarin | AMRN - 売上総利益





売上総利益 変化する 日付
AbbVie USD 12.54B 474M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amarin USD 23.17M 961K 2025-12
AstraZeneca USD 12.86B 251M 2026-06
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
DBV Technologies USD 2.77M 33.21M 2025-09
GlaxoSmithKline GBP 6.51B 757M 2026-06
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Heron Therapeutics USD 29.47M 3.17M 2025-12
Ionis Pharmaceuticals USD 265M 22M 2026-06
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novartis USD 11.24B 1.18B 2026-06